伊朗丙型肝炎病毒感染的潜在流行：行动呼吁。
Lurking epidemic of hepatitis C virus infection in Iran: A call to action.
作者信息
Taherkhani Reza, Farshadpour Fatemeh
机构信息
the Persian Gulf Biomedical Research Center, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran.
the Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran.
出版信息
World J Hepatol. 2017 Aug 28;9(24):1040-1042. doi: 10.4254/wjh.v9.i24.1040.
Abstract
Despite having a relatively low prevalence in the Iranian general population, the burden of hepatitis C virus (HCV) infection is on the rise, and hepatitis C is predicted to be the most important leading cause of viral hepatitis-related mortality in the near future in Iran. The recent population-based epidemiological studies have revealed the predominant role of injecting drug use in increasing prevalence of HCV infection. Undoubtedly, new management paradigm is required to drive down the rising wave of hepatitis C in Iran. Priority should be given to young injecting drug users as the cornerstone of the lurking epidemic of HCV infection in Iran.
摘要
尽管丙型肝炎病毒（HCV）感染在伊朗普通人群中的患病率相对较低，但感染负担却在上升，预计在不久的将来，丙型肝炎将成为伊朗病毒性肝炎相关死亡的最重要主要原因。最近基于人群的流行病学研究表明，注射吸毒在丙型肝炎病毒感染患病率上升中起主要作用。毫无疑问，需要新的管理模式来压低伊朗丙型肝炎不断上升的浪潮。应将年轻注射吸毒者作为伊朗丙型肝炎病毒潜伏性流行的基石予以优先关注。
相似文献
1
Lurking epidemic of hepatitis C virus infection in Iran: A call to action.伊朗丙型肝炎病毒感染的潜在流行：行动呼吁。
World J Hepatol. 2017 Aug 28;9(24):1040-1042. doi: 10.4254/wjh.v9.i24.1040.
2
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.伊朗吸食冰毒者的药物使用和风险行为特征，以及艾滋病毒、丙型肝炎和乙型肝炎的流行情况。
Int J Drug Policy. 2019 Nov;73:129-134. doi: 10.1016/j.drugpo.2019.09.018. Epub 2019 Oct 22.
3
HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.伊朗德黑兰注射吸毒者中的 HIV、丙型肝炎病毒和乙型肝炎病毒合并感染。
Int J Infect Dis. 2010 Jan;14(1):e28-33. doi: 10.1016/j.ijid.2009.03.002. Epub 2009 May 21.
4
Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.伊朗丙型肝炎病毒感染的肝脏疾病负担以及各种治疗策略对疾病负担的潜在影响。
Hepat Mon. 2016 Jun 14;16(7):e37234. doi: 10.5812/hepatmon.37234. eCollection 2016 Jul.
5
The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.丙型肝炎治疗和人类免疫缺陷病毒（HIV）合并感染对阿姆斯特丹注射吸毒者丙型肝炎疾病负担的影响。
Addiction. 2012 Mar;107(3):614-23. doi: 10.1111/j.1360-0443.2011.03654.x.
6
Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.伊朗注射吸毒者中丙型肝炎病毒的分子流行病学：HCV 基因型流行率随时间的轻微变化。
Arch Virol. 2012 Oct;157(10):1959-65. doi: 10.1007/s00705-012-1369-9. Epub 2012 Jun 13.
7
Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.在阿富汗地域差异较大的静脉注射吸毒者中丙型肝炎基因型分布和同源性。
J Med Virol. 2013 Jul;85(7):1170-9. doi: 10.1002/jmv.23575.
8
Epidemiology of hepatitis E virus in Iran.伊朗戊型肝炎病毒的流行病学
World J Gastroenterol. 2016 Jun 14;22(22):5143-53. doi: 10.3748/wjg.v22.i22.5143.
9
Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.2015 年伊朗囚犯中乙型肝炎病毒和丙型肝炎病毒的流行情况和危险因素：一项全国性的生物行为监测调查。
Trop Med Int Health. 2018 Jun;23(6):641-649. doi: 10.1111/tmi.13065. Epub 2018 May 25.
10
[Epidemiology of hepatitis C and human immunodeficiency virus infections among injecting drug users in Hungary--what's next?].[匈牙利注射吸毒者中丙型肝炎和人类免疫缺陷病毒感染的流行病学——接下来会怎样？]
Orv Hetil. 2010 Mar 7;151(10):365-71. doi: 10.1556/OH.2010.28821.
引用本文的文献
1
Prevalence and Genotypes of Hepatitis C Infection Among Hemodialysis Patients in Bushehr, Iran.伊朗布什尔血液透析患者丙型肝炎感染的患病率及基因型
Oman Med J. 2023 Mar 31;38(2):e481. doi: 10.5001/omj.2023.60. eCollection 2023 Mar.
2
Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain.西班牙巴塞罗那的巴基斯坦移民中丙型肝炎病毒感染、基因型和亚型的流行情况
Infect Drug Resist. 2022 Aug 18;15:4637-4644. doi: 10.2147/IDR.S367715. eCollection 2022.
3
Viral Hepatitis - The Road Traveled and the Journey Remaining.病毒性肝炎——走过的路与待走的旅程
Hepat Med. 2022 Mar 9;14:13-26. doi: 10.2147/HMER.S352568. eCollection 2022.
4
Prevalence, genotype distribution and mutations of hepatitis B virus and the associated risk factors among pregnant women residing in the northern shores of Persian Gulf, Iran.伊朗波斯湾北部沿海地区孕妇中乙型肝炎病毒的流行率、基因型分布和突变以及相关危险因素。
PLoS One. 2022 Mar 10;17(3):e0265063. doi: 10.1371/journal.pone.0265063. eCollection 2022.
5
Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures.埃塞俄比亚南部病毒性肝炎的负担及传播风险：预防与控制措施所需证据
Risk Manag Healthc Policy. 2021 Dec 1;14:4843-4852. doi: 10.2147/RMHP.S336776. eCollection 2021.
6
Prevalence and Predominant Genotype of Hepatitis C Virus Infection and Associated Risk Factors among Pregnant Women in Iran.伊朗孕妇丙型肝炎病毒感染的流行情况和主要基因型及相关危险因素。
Biomed Res Int. 2021 Sep 18;2021:9294276. doi: 10.1155/2021/9294276. eCollection 2021.
7
Hepatitis B and Hepatitis C Viral Infections and Associated Factors Among Prisoners in Northeast Ethiopia.埃塞俄比亚东北部囚犯中的乙型和丙型肝炎病毒感染及相关因素
J Blood Med. 2021 Jul 5;12:561-570. doi: 10.2147/JBM.S314556. eCollection 2021.
8
Dynamics of host immune responses to SARS-CoV-2.宿主对新型冠状病毒2（SARS-CoV-2）免疫反应的动力学
World J Clin Cases. 2021 Jun 26;9(18):4480-4490. doi: 10.12998/wjcc.v9.i18.4480.
9
Seroepidemiology of Hepatitis B and C Virus Infections: A Five-Year Retrospective Study among Blood Donors in Saboba District in the Northern Region of Ghana.乙型肝炎和丙型肝炎病毒感染的血清流行病学：加纳北部萨博巴地区献血者五年回顾性研究。
Biomed Res Int. 2021 May 11;2021:5599705. doi: 10.1155/2021/5599705. eCollection 2021.
10
Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.抗体依赖性增强作用与新冠肺炎的关键模式：可能性与思考。
Med Princ Pract. 2021;30(5):422-429. doi: 10.1159/000516693. Epub 2021 Apr 21.
本文引用的文献
1
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline.伊朗丙型肝炎临床管理建议：基于共识的国家指南
Hepat Mon. 2016 Aug 13;16(8):e40959. doi: 10.5812/hepatmon.guideline. eCollection 2016 Aug.
2
Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.伊朗丙型肝炎病毒感染的肝脏疾病负担以及各种治疗策略对疾病负担的潜在影响。
Hepat Mon. 2016 Jun 14;16(7):e37234. doi: 10.5812/hepatmon.37234. eCollection 2016 Jul.
3
Hepatitis C virus: Promising discoveries and new treatments.丙型肝炎病毒：有前景的发现与新疗法
World J Gastroenterol. 2016 Jul 28;22(28):6393-401. doi: 10.3748/wjg.v22.i28.6393.
4
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions.在选定的西欧、俄罗斯和以色列地区丙型肝炎基因型分布的新发现。
J Clin Virol. 2016 Aug;81:82-9. doi: 10.1016/j.jcv.2016.05.010. Epub 2016 May 24.
5
Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.伊朗南部献血者中输血传播病毒感染的患病率及趋势：一项为期11年的回顾性研究
PLoS One. 2016 Jun 16;11(6):e0157615. doi: 10.1371/journal.pone.0157615. eCollection 2016.
6
Advances in hepatitis C therapy: What is the current state - what come's next?丙型肝炎治疗的进展：现状如何——接下来会怎样？
World J Hepatol. 2016 Jan 28;8(3):139-47. doi: 10.4254/wjh.v8.i3.139.
7
Update on hepatitis C: Direct-acting antivirals.丙型肝炎最新进展：直接作用抗病毒药物
World J Hepatol. 2015 Dec 8;7(28):2829-33. doi: 10.4254/wjh.v7.i28.2829.
8
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.当今治疗模式下丙型肝炎病毒感染的当前及未来疾病负担 - 第3卷
J Viral Hepat. 2015 Dec;22 Suppl 4:21-41. doi: 10.1111/jvh.12476.
9
Epidemiology of hepatitis C virus in Iran.伊朗丙型肝炎病毒的流行病学
World J Gastroenterol. 2015 Oct 14;21(38):10790-810. doi: 10.3748/wjg.v21.i38.10790.
10
Prevalence of hepatitis C virus genotypes in Iranian patients: a systematic review and meta-analysis.伊朗患者丙型肝炎病毒基因型的流行率：一项系统评价和荟萃分析。
Hepat Mon. 2014 Dec 24;14(12):e22915. doi: 10.5812/hepatmon.22915. eCollection 2014 Dec.
Zotero 插件